Implementation of Specific Tailored Exercises Program Versus Exergaming Exercises on Cobb Angle in the Treatment of Adolescent Idiopathic Scoliosis. (IS)

February 9, 2026 updated by: Randa Ahmed Amin, Cairo University

Implementation of Specific Tailored Exercises Program Versus Exergaming Exercises on Cobb Angle in the Treatment of Adolescent Idiopathic Scoliosis: a Randomized Controlled Trial

this study will be conducted to investigate the difference between specific tailored exercise program and exergaming exercises on Cobb's angle, angle of trunk rotation, pulmonary function and quality of the life in adolescent idiopathic scoliosis.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Adolescent idiopathic scoliosis is a structural spinal disorder that occurs during puberty and lacks a definitive etiology. The spinal deviation of the thoracic region occurs more frequently in adolescent and typical manifestations may include noticeable spinal deformities, impair posture and restrict body movement . Existing studies on scoliosis-specific exercises like Schroth, lyon and side shifts approaches have shown positive outcomes in reducing curvature progression and enhancing postural stability. Also, the exergaming exercises enhance postural deformity by providing real-time body movement of postural correction exercises through games.However, research on the tailored program for AIS is limited, leading to uncertainties about it's their clearance effect. Recent literature underscores the need for standardized protocols.The current study aims to assess the evidence of the specific tailored program based on differential approaches of the scoliosis specific exercises as (schroth, lyon and side shifts) methods. Also, asses the evidence of the specific customized tailored exergaming exercises, to identifying their impact on cobb's angle, angle of trunk rotation, pulmonary function and quality of life.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
54

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Thoracic spine region with C-shaped scoliosis
  • Individuals aged 10-18 years
  • Cobb's angle from 10 to 25 degrees
  • Both genders (male and female)
  • Adolescent idiopathic scoliosis

Exclusion Criteria:

  • Mental health disorders
  • Neuromuscular or rheumatic diseases
  • A history of spinal surgery
  • Patients been prescribed brace treatment
  • Leg length discrepancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Specific Tailored Exercises Program
eighteen patients will receive Specific Tailored Exercises Program plus traditional physical therapy three times per week for three months
Other: Specific Tailored Exercises Program
the patients will receive a specific tailored exercise program in the form of corrective exercises, positioning, mirror therapy, ADL adaptation, and instructions in addition to traditional physical therapy treatment.
Other: traditional physical therapy
the patients will receive traditional treatment only of the intervention in the form of stretching, strengthening, core stabilization and breathing exercises
Experimental: Exergaming Exercises
eighteen patients will receive Exergaming Exercises plus traditional physical therapy three times per week for three months
Other: traditional physical therapy
the patients will receive traditional treatment only of the intervention in the form of stretching, strengthening, core stabilization and breathing exercises
Other: Exergaming Exercises
Every participant in group B will be received an exergaming exercises in form of a series of Kinect training game, sports island freedom game . dance evolution game and Kinect sports games designed for Xbox 360 Kinect console. The games will be projected onto a 24-Inch screen monitor. Each session consisted of playing 1-2 trials in a row of each game for 45-60 minutes in addition to traditional physical therapy
Active Comparator: traditional physical therapy
eighteen patients will receive traditional physical therapy three times per week for three months
Other: traditional physical therapy
the patients will receive traditional treatment only of the intervention in the form of stretching, strengthening, core stabilization and breathing exercises

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Cobb's angle
Time Frame: up to three months
cobbs angle will be measured by x-ray. This method quantifies the lateral spinal curvature measured on a radiograph in the coronal plane, using anterior-posterior (AP) or posterior-anterior (PA) radiographs.A Cobb angle in the range of 10 to 20 degrees is considered as mild scoliosis. Scoliosis severity is moderate when the Cobb angle ranges from 20 to 40 degrees.
up to three months
the angle of trunk rotation
Time Frame: up to three months
Scoliometer mobile applications is a valid and reliable method used to assess the angle of trunk rotation. It is a portable, accessible and easy tracking and follow up. Visual interface and digital readout. Save and track angle trunk rotation values over time
up to three months
flow rate of inhalation
Time Frame: up to three months
The flow rate of inhalation in respiratory physiology refers to the rate at which air moves into the lungs during inspiration, i.e., The volume of air that enters the lungs per unit of time during inspiration. (e.g., mL/sec ). In a flow-based incentive spirometer, this flow rate is indicated by rising elements (e.g., balls) in the device that reflect how quickly air is drawn in during inspiration. For proper medication delivery from a Dry Powder Inhaler (DPI), a flow rate of inhalation of greater than 60 L/min is generally considered optimal.
up to three months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
life disability
Time Frame: up to three months
It will be measured by the Arabic version of the Scoliosis Research Society -22 Questionnaire (SRS-22). The scale consists of 22 questions and 5 subdimensions, namely, pain, self-image, spinal functions, mental health, and treatment satisfaction. All of these sections are evaluated separately or by summing all questions under a total result score. Scores were calculated by assigning a value between 1 and 5 for each question. Accordingly, the lowest total score of the survey was 1, and the highest total score was 5, with higher scores indicating better QoL.
up to three months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 10, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 10, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 10, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 30, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 9, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 17, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 17, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 9, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • P.T.REC/012/006202

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Scoliosis

Clinical Trials on Specific Tailored Exercises Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings